Junxing Huang

2.1k total citations
82 papers, 1.7k citations indexed

About

Junxing Huang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Junxing Huang has authored 82 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Molecular Biology, 35 papers in Cancer Research and 13 papers in Oncology. Recurrent topics in Junxing Huang's work include Cancer-related molecular mechanisms research (22 papers), Circular RNAs in diseases (15 papers) and RNA modifications and cancer (14 papers). Junxing Huang is often cited by papers focused on Cancer-related molecular mechanisms research (22 papers), Circular RNAs in diseases (15 papers) and RNA modifications and cancer (14 papers). Junxing Huang collaborates with scholars based in China, Finland and United States. Junxing Huang's co-authors include Hong Yu, Mei Lin, Maosong Lin, Jun Ye, Haihui Sheng, Min Sha, Jiang Lin, Gaohua Han, Hengjun Gao and Lingchuan Guo and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Junxing Huang

82 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junxing Huang China 26 1.0k 711 224 188 165 82 1.7k
Jingjing Pan China 22 1.3k 1.3× 1.1k 1.5× 185 0.8× 246 1.3× 207 1.3× 98 2.0k
Jinghuan Li China 21 1.4k 1.4× 1.0k 1.4× 199 0.9× 107 0.6× 132 0.8× 51 2.2k
Qiyun Tang China 23 625 0.6× 366 0.5× 282 1.3× 168 0.9× 179 1.1× 65 1.3k
Suxia Han China 24 1.0k 1.0× 518 0.7× 445 2.0× 299 1.6× 131 0.8× 75 1.8k
Pingfu Hou China 28 1.8k 1.7× 1.0k 1.4× 324 1.4× 196 1.0× 73 0.4× 60 2.4k
Zhenjian Zhuo China 27 2.1k 2.0× 772 1.1× 269 1.2× 125 0.7× 158 1.0× 106 2.7k
Mahshid Deldar Abad Paskeh Iran 19 1.0k 1.0× 650 0.9× 210 0.9× 188 1.0× 55 0.3× 33 1.5k
Yao Yuan China 20 855 0.8× 376 0.5× 500 2.2× 185 1.0× 154 0.9× 72 1.6k
Katharina Leithner Austria 25 887 0.9× 509 0.7× 270 1.2× 351 1.9× 306 1.9× 45 2.0k
Gongwei Wu China 15 814 0.8× 474 0.7× 209 0.9× 112 0.6× 56 0.3× 17 1.3k

Countries citing papers authored by Junxing Huang

Since Specialization
Citations

This map shows the geographic impact of Junxing Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junxing Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junxing Huang more than expected).

Fields of papers citing papers by Junxing Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junxing Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junxing Huang. The network helps show where Junxing Huang may publish in the future.

Co-authorship network of co-authors of Junxing Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Junxing Huang. A scholar is included among the top collaborators of Junxing Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junxing Huang. Junxing Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shi, W., et al.. (2025). Disparities in Drug Allergy Labeling in China: Half of All Labels Are Attributed to ß-Lactams. Journal of Investigational Allergology and Clinical Immunology. 35(6). 463–465. 1 indexed citations
2.
Sun, Li, et al.. (2024). Astragalus polysaccharide enhances the therapeutic efficacy of cisplatin in triple-negative breast cancer through multiple mechanisms. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 33(3). 641–651. 1 indexed citations
3.
Liu, Lei, Hong‐Ren Yu, Gaohua Han, et al.. (2024). RNA-binding motif protein 28 enhances angiogenesis by improving STAT3 translation in hepatocellular carcinoma. Cancer Letters. 604. 217191–217191. 2 indexed citations
4.
Li, Fei, Yuanyuan Ren, Qianqian Zhang, et al.. (2023). Targeting Esophageal Squamous Cell Carcinoma by Combining Copper Ionophore Disulfiram and JMJD3/UTX Inhibitor GSK J4. Cancers. 15(22). 5347–5347. 1 indexed citations
5.
Liu, Xia, et al.. (2023). NAT10 Promotes Malignant Progression of Lung Cancer via the NF-κB Signaling Pathway. Discovery Medicine. 35(179). 936–936. 7 indexed citations
6.
Zhang, Wei, Feng Shen, Xi Yang, et al.. (2021). YTH Domain Proteins: A Family of m6A Readers in Cancer Progression. Frontiers in Oncology. 11. 629560–629560. 55 indexed citations
7.
Song, Yang, Gaohua Han, Quansheng Chen, et al.. (2021). Au-Pt Nanoparticle Formulation as a Radiosensitizer for Radiotherapy with Dual Effects. International Journal of Nanomedicine. Volume 16. 239–248. 53 indexed citations
8.
Shen, Wenhao, Hailin Zhou, Teng Liu, et al.. (2020). The potential clinical applications of radionuclide labeled/doped gold-based nanomaterials. SHILAP Revista de lepidopterología. 1(4). 186–195. 7 indexed citations
9.
Li, Xing & Junxing Huang. (2020). Role of lncRNA MEG3 as ceRNA of miR-21 in cancer. 47(1). 35–38. 1 indexed citations
10.
Guo, Ting, Mei Lin, Junxing Huang, et al.. (2019). Biological Characteristics and Carrier Functions of Pegylated Manganese Zinc Ferrite Nanoparticles. Journal of Nanomaterials. 2019. 1–10. 8 indexed citations
11.
Guo, Ting, Mei Lin, Junxing Huang, et al.. (2018). The Recent Advances of Magnetic Nanoparticles in Medicine. Journal of Nanomaterials. 2018. 1–8. 72 indexed citations
12.
Lin, Mei, Junxing Huang, Xingmao Jiang, et al.. (2016). A combination hepatoma-targeted therapy based on nanotechnology: pHRE-Egr1-HSV-TK/131I-antiAFPMcAb-GCV/MFH. Scientific Reports. 6(1). 33524–33524. 14 indexed citations
13.
Guo, Qing, Jia He, Feng Shen, et al.. (2016). TCN, an AKT inhibitor, exhibits potent antitumor activity and enhances radiosensitivity in hypoxic esophageal squamous cell carcinoma in vitro and in vivo. Oncology Letters. 13(2). 949–954. 5 indexed citations
14.
Lin, Maosong, Yiwei Fu, Hong Yu, & Junxing Huang. (2015). Gastric heterotopic pancreas masquerading as a stromal tumor: A case report. Oncology Letters. 10(4). 2355–2358. 5 indexed citations
15.
Guo, Qing, Shengbin Dai, Feng Shen, et al.. (2014). VEGF +405G/C (rs2010963) polymorphisms and digestive system cancer risk: a meta-analysis. Tumor Biology. 35(5). 4977–4982. 7 indexed citations
16.
Sha, Min, et al.. (2014). Celastrol Induces Apoptosis of Gastric Cancer Cells by miR-21 Inhibiting PI3K/Akt-NF-κB Signaling Pathway. Pharmacology. 93(1-2). 39–46. 58 indexed citations
17.
Lin, Mei, Dongsheng Zhang, Junxing Huang, et al.. (2013). The anti-hepatoma effect of nanosized Mn–Zn ferrite magnetic fluid hyperthermia associated with radiationin vitroandin vivo. Nanotechnology. 24(25). 255101–255101. 29 indexed citations
18.
Zhang, Lixin, et al.. (2013). The effect of CD33 expression on inflammatory response in chronic obstructive pulmonary disease. Immunological Investigations. 42(8). 701–710. 9 indexed citations
19.
Xu, Hongtao, Jun Ye, Lixing Zhang, et al.. (2011). Changes in the Proportions of CD4+T Cell Subsets Defined by CD127 and CD25 Expression during HBV Infection. Immunological Investigations. 41(3). 290–303. 1 indexed citations
20.
Huang, Junxing. (2005). Relationship between proliferative activity of cancer cells and clinicopathological factors in patients with esophageal squamous cell carcinoma. World Journal of Gastroenterology. 11(19). 2956–2956. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jingjing Pan Breakdown of academic impact, for papers by Jinghuan Li Breakdown of academic impact, for papers by Qiyun Tang Breakdown of academic impact, for papers by Suxia Han Breakdown of academic impact, for papers by Pingfu Hou Breakdown of academic impact, for papers by Zhenjian Zhuo Breakdown of academic impact, for papers by Mahshid Deldar Abad Paskeh Breakdown of academic impact, for papers by Yao Yuan Breakdown of academic impact, for papers by Katharina Leithner Breakdown of academic impact, for papers by Gongwei Wu
Rankless by CCL
2026